Search

Your search keyword '"P. Houssel-Debry"' showing total 122 results

Search Constraints

Start Over You searched for: Author "P. Houssel-Debry" Remove constraint Author: "P. Houssel-Debry"
122 results on '"P. Houssel-Debry"'

Search Results

2. Inevitability of disease recurrence after liver transplantation for NAFLD cirrhosis

3. AFP score and metroticket 2.0 perform similarly and could be used in a 'within-ALL' clinical decision tool

4. Involvement of circulating soluble HLA-G after liver transplantation in the low immunogenicity of hepatic allograft.

5. Poor Patient and Graft Outcome After Induction Treatment by Antithymocyte Globulin in Recipients of a Kidney Graft After Nonrenal Organ Transplantation.

6. R3-AFP score is a new composite tool to refine prediction of hepatocellular carcinoma recurrence after liver transplantation

7. Mortality after Transplantation for Hepatocellular Carcinoma: A Study from the European Liver Transplant Registry

8. International study on the outcome of locoregional therapy for liver transplant in hepatocellular carcinoma beyond Milan criteria

9. Patients Treated for HCV Infection and Listed for Liver Transplantation in a French Multicenter Study: What Happens at Five Years?

10. Comparison of the effect of direct-acting antiviral with and without ribavirin on cyclosporine and tacrolimus clearance values: results from the ANRS CO23 CUPILT cohort

11. Pharmacogenetic-Whole blood and intracellular pharmacokinetic-Pharmacodynamic (PG-PK2-PD) relationship of tacrolimus in liver transplant recipients.

12. Localisation hépatique isolée d’une histiocytose langerhansienne : à propos d’un cas

13. Poor Patient and Graft Outcome After Induction Treatment by Antithymocyte Globulin in Recipients of a Kidney Graft After Nonrenal Organ Transplantation

14. Development of an organ failure score in acute liver failure for transplant selection and identification of patients at high risk of futility.

15. Influence de 4 solutions de préservation sur la durée de réanimation, la survie du greffon et du patient après transplantation hépatique

16. Influence of 4 preservation solutions on ICU stay, graft and patient survival following liver transplantation

17. Morbid obesity increases death and dropout from the liver transplantation waiting list: A prospective cohort study

18. Tacrolimus Concentrations Measured in Excreted Bile in Liver Transplant Recipients The STABILE Study

19. Long term results of liver transplantation for alpha-1 antitrypsin deficiency.

20. Therapeutic anticoagulation after liver transplantation is not useful among patients with pre‐transplant Yerdel‐grade I/II portal vein thrombosis: A two‐center retrospective study

21. Baseline serum ferritin is an independent predictive factor of mortality in patients with chronic hepatitis C after long term follow-up

22. P217 Usefulness of systematic liver biopsy during a surgery for inflammatory bowel disease for the diagnosis of primary sclerosing cholangitis

23. Characteristics, management, and outcome of tuberculosis after liver transplant: A case series and literature review

24. Risk analysis of ischemic-type biliary lesions after liver transplant using octogenarian donors

25. A high performance liquid chromatography tandem mass spectrometry for the quantification of tacrolimus in human bile in liver transplant recipients

26. P0709 : Survival of patients infected by chronic hepatitis c and f0f1 fibrosis at baseline after a 15 years follow-up

27. Portal cavernoma or chronic non cirrhotic extrahepatic portal vein obstruction

28. Mortality after Transplantation for Hepatocellular Carcinoma: A Study from the European Liver Transplant Registry

29. Influence de 4 solutions de préservation sur la durée de réanimation, la survie du greffon et du patient après transplantation hépatique

31. OR01: A Low Transversal Psoas Muscle Thickness Assessed by Computed Tomography (CT) Scan is a Prognostic Factor in Cirrhotic Patients on Waiting-List for Liver Transplantation

32. Oral pulmonary vasoactive drugs achieve hemodynamic eligibility for liver transplantation in portopulmonary hypertension.

34. High Intrapatient Variability of Tacrolimus Exposure in the Early Period After Liver Transplantation Is Associated With Poorer Outcomes

35. Sofosbuvir-Based Regimens in HIV/HCV Coinfected Patients After Liver Transplantation: Results From the ANRS CO23 CUPILT Study

36. Bariatric surgery and liver transplantation, here we are now: A French nationwide retrospective study

37. Direct-acting antiviral agent–based regimen for HCV recurrence after combined liver-kidney transplantation: Results from the ANRS CO23 CUPILT study

38. Efficacy and Safety of Everolimus and Mycophenolic Acid With Early Tacrolimus Withdrawal After Liver Transplantation: A Multicenter Randomized Trial

39. Rivaroxaban Prophylaxis in Noncirrhotic Portal Vein Thrombosis.

40. Drug transporters are implicated in the diffusion of tacrolimus into the T lymphocyte in kidney and liver transplant recipients: Genetic, mRNA, protein expression, and functionality

41. HCV eradication does not protect from fibrosis progression in patients with fibrosing cholestatic hepatitis after liver transplantation

43. Risk factors of de novomalignancies after liver transplantation: a French national study on 11004 adult patients

44. Covid-19 in liver transplant recipients: the French SOT COVID registry

47. NON-INVASIVE DIAGNOSIS AND FOLLOW-UP IN LIVER TRANSPLANTATION

49. Efficacy of Sofosbuvir and Daclatasvir in Patients With Fibrosing Cholestatic Hepatitis C After Liver Transplantation.

50. Dexamethasone improves clinical and biological tolerance of transcatheter arterial chemoembolization for hepatocellular carcinoma.

Catalog

Books, media, physical & digital resources